☆ 4.4 Editorial Material

CYP2D6 Genotype as a Marker for Benefit of Adjuvant Tamoxifen in Postmenopausal Women: Lessons Learned

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)

Journal

JOURNAL OF THE NATIONAL CANCER INSTITUTE

Volume 104, Issue 6, Pages 427-428

Publisher

OXFORD UNIV PRESS INC

DOI: 10.1093/jnci/djs139

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.